U.S. Court of Appeals for the Federal Circuit, 2011

King Pharmaceuticals, Inc. v. Sandoz Inc.

King Pharmaceuticals, Inc. v. Sandoz Inc.
U.S. Court of Appeals for the Federal Circuit · Decided March 18, 2011

King Pharmaceuticals, Inc. v. Sandoz Inc.

Opinion

NOTE: This order is nonprecedential United States Court of AppeaIs for the FederaI Circuit KING PHARMACEUTICALS, INC. AND KING PHARMACEUTICALS RESEARCH AND DEvELOPMENT, INC., ' Plaintiffs-Appellants, 4 and PHARMACEUTICAL IP HOLDING, INC., Plaintiff-Appellan,t, V. SANDOZ INC., Defendant-Appellee.

2011-1227 Appea1 from the United States District Court for the District of New Je1'Sey in case n0. 08-CV-5974, Chief Judge Ga1‘rett E. BroWn, Jr. ON MOTION ORDER Sandoz Inc. moves without opposition to amend the caption to reflect that the official corporate name of Defen- K]NG PHARMA V. SANDOZ 2 dant-Appe]lee Sandoz does not include a comma between "Sandoz" and "Inc.” ACco1‘ding1y, I'1‘ ls 0RDERED THAT: The motion is granted The revised official caption is reflected above FoR THE CoURT 8 lsi Jan Horba1__\g Date J an Horba1y _ C1erk cci Char1eS M. Lizza, Esq.

Miche1le S. Rhyu, Esq. |:g|_£b ' AppEA|,sFBR Mart1n B. Pavane, Esq. 5-31,gE'~g§B€£AL mRcU“- ma 1 aim IIl|-DRBA|!

1151

Case-law data current through December 31, 2025. Source: CourtListener bulk data.